TLX News: Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter - 17th Apr 2023, 8:15pm

[annb0t]

MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 31 March 2023 (Q1 2023). All figures are in AUD$ unless otherwise stated[1] and provided on an unaudited basis. (PRNewsfoto/Telix Pharmaceuticals Limited)

Summary

Total revenue for the quarter reaches $100.1M, driven by global sales of Illuccix®, Telix's prostate c...

>>> Read more: Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter